StockTipsArenaBeta

BUY Marksans Pharma Limited — Vinay Rajani, HDFC Securities

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byVinay Rajani, HDFC SecuritiesHorizon: Swing (≤2wk)24 Sept 2026via NDTV Profit (Live)

Entry₹345.8Inferred
Target₹370
Total upside +7.00% (call closed)
Stop loss₹326-5.73% risk
Exit₹32630 Sept 2026, 11:00 am
Stop-loss hit-5.73%
Follow Vinay Rajani for new calls(26% target hit, 61 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Sept 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·29 Sept · today

Neutral / worth noting (2)

Marksans Pharma Opens SEBI-Mandated Window for Re-Lodging Physical Share Transfers

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)

Marksans Pharma opens special window for re-lodgement of physical share transfer requests

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Vinay Rajani, HDFC Securities

Every call and its outcome